Current treatments for atrial fibrillation (AFib), a common heart condition characterized by fast and irregular beats that can lead to stroke and heart failure, have multiple side effects and are ineffective for preventing AFib recurrence.
Related Keywords
United Kingdom , Massachusetts , United States , British , American , Serguei Melnitchouk , George Tellides , Claudio Vinegoni , Samuel Sossalla , Richardn Pierson , Deutsche Forschungsgemeinschaft , David Rohde , Noor Momin , Filipk Swirski , Danielle Ellis , Matthias Nahrendorf , Aneesh Bapat , I Hsiu Lee , Nina Kumowski , Daniel Keller , Andrew Lewis , Hana Seung , Masahiro Yamazoe , Barbara Casadei , Yoshiko Iwamoto , Alexandre Paccalet , Richardn Mitchell , Jana Grune , Ralph Weissleder , Fadi Pulous , Jochenk Lennerz , Maximilianj Schloss , Maarten Hulsmans , Constanze Bening , Oriol Iborra Egea , Steffen Pabel , Gregoryr Wojtkiewicz , Patrickt Ellinor , Artery Disease Branch , National Institutes Of Health , European Union , Research Institute , National Heart , Oxford Biomedical Research Centre , British Heart Foundation , Men Health , Mercator , Blood Institute , Division Of Cardiovascular Sciences , American Heart Association , Massachusetts General Hospital , Systems Biology , Richard Moerschner Endowed , Institute Chair , Michelle Olive , Coronary Artery Disease Branch , Cardiovascular Sciences , Ursula Green , Antoni Bayes Genis , Chin Siang Ong , George Tolis , National Institutes , Biomedical Research Centre ,
comparemela.com © 2020. All Rights Reserved.